CLINICAL_TRIALS
trial_result
· 2019-03-11
Clinical Trial Update: Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease [Phase 4]
Summary
Phase 4 clinical trial assessing the effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dong-A University | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED